The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma-Letter

Clin Cancer Res. 2020 Jan 15;26(2):518-519. doi: 10.1158/1078-0432.CCR-19-2441.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adenocarcinoma of Lung*
  • ErbB Receptors / genetics
  • Exons
  • Humans
  • Lung Neoplasms / genetics*
  • Protein Kinase Inhibitors

Substances

  • Protein Kinase Inhibitors
  • EGFR protein, human
  • ErbB Receptors